4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001628280-25-001898
Pres., R&D, and CMO sold 1,689 shares at $273.41 ($461,789)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Taub Rebecca Pres., R&D, and CMO | 2025-01-17 | Sale | −1,689 | $273.41 | $461,789 | 457,310 | D |
| Open-market sales · 1,689 sh · avg $273.41 · $461,789 | |||||||
Loading xslF345X05/wk-form4_1737158698.xml…